3BBLACKBIOBSE3B BlackBio Dx LtdLowNeutral
Announced Wed, 20 May · 15:27 IST

3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....

3BBLACKBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.0%1-day move
₹1250.00
prior close
₹1264.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.0-4.8-1.2-4.1-1.6-11.7+0.3-3.6+2.5
Up moveDown movePending
AI summary

The company has announced that its Board of Directors will meet on Friday, 29th May 2026 to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter/financial year ended 31st March 2026. The meeting will also discuss dividend recommendation for FY 2025-26. This is a standard pre-meeting intimation filing under SEBI regulations and does not contain actual financial results or performance data. The trading window for designated persons has been closed since 1st April 2026 and will reopen 48 hours after the results announcement.

Likely market impact

This is a routine procedural filing announcing the date of the board meeting where FY2026 results will be approved. Actual financial performance and dividend details will be disclosed only after the meeting concludes. No investment signals can be derived from this intimation alone.